Results 21 to 30 of about 148,412 (201)

Clinical results after high-dose intensity-modulated radiotherapy for high-risk prostate cancer [PDF]

open access: yes, 2012
Purpose. Patients with high-risk prostate cancer (PC) can be treated with high-dose intensity-modulated radiotherapy (IMRT) and long-term androgen deprivation (AD).
FONTEYNE, VALERIE   +4 more
core   +2 more sources

A prospective, multicenter study on the clinical effectiveness of abiraterone in metastatic castration-resistant prostate cancer in Korea: Pre- vs. post-chemotherapy [PDF]

open access: yesInvestigative and Clinical Urology, 2023
Purpose: The proper treatment sequence for administering abiraterone acetate plus prednisolone (AAP) and chemotherapeutic agents has not yet been elucidated for metastatic castration-resistant prostate cancer (mCRPC).
Seung-hwan Jeong   +19 more
doaj   +1 more source

Immunochromatographic diagnostic test analysis using Google Glass. [PDF]

open access: yes, 2014
We demonstrate a Google Glass-based rapid diagnostic test (RDT) reader platform capable of qualitative and quantitative measurements of various lateral flow immunochromatographic assays and similar biomedical diagnostics tests.
Caire, Romain   +5 more
core   +1 more source

Oncologic Outcomes of Radical Prostatectomy and Prognostic Stratification in Patients with Clinically Locally Advanced Prostate Cancer [PDF]

open access: yes, 2017
Oncologic outcomes of radical prostatectomy in 106 patients with clinically locally advanced prostate cancer were demonstrated. The mean follow-up was 50.6 (12-129) months.
Banas, O. (Oleksandr)   +6 more
core   +2 more sources

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden [PDF]

open access: yes, 2008
BACKGROUND: Prostate-specific antigen (PSA) is widely used to detect prostate cancer. The low positive predictive value of elevated PSA results in large numbers of unnecessary prostate biopsies.
Andrew J Vickers   +8 more
core   +3 more sources

Daily Variation of Free PSA/Total PSA Ratio

open access: yesSakarya Medical Journal, 2011
Giriş: Total PSA(tPSA)'dan farklı bir metabolizmaya sahip olan serbest PSA(sPSA)'nın, tPSA'dan farklı bir günlük varyasyonunun olup olmadığını; varsa, serbest/total PSA oranının gün içinde değişip değişmediğini araştırmak istedik. Materyal ve Metod: Yaş ortalaması 61( 40-84 arası) olan ve üroloji dışında diğer kliniklerde yatan 33 erkek ...
Sağlam, Hasan Salih, Özdemir, Fatma
openaire   +3 more sources

Is serum prostate-specific antigen a diagnostic marker for benign and malignant breast tumors in women?

open access: yesInternational Journal of Preventive Medicine, 2015
Background: Breast cancer is the most common cancer in women. Prostate-specific antigen (PSA) is a marker of prostate gland malignancy, which has been considered in cases with breast cancer in recent years.
Seyed Hasan Emami Razavi   +4 more
doaj   +1 more source

The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density [PDF]

open access: yes, 1995
Objectives: The ratio between free and total prostate-specific antigen (PSA) in serum (F/T ratio) was shown to improve the specificity of total serum PSA for the detection of prostate carcinoma in selected populations. In this study, the value of the F/T
Bangma, C.H. (Chris)   +3 more
core   +2 more sources

EFFECTS OF CHRONIC RENAL FAILURE AND HEMODIALYSIS ON SERUM PSA, FREE PSA, FREE/TOTAL PSA RATIOS

open access: yesUrology Research and Practice, 2019
Little is known of the impact of hemodialysis on serum total (tPSA) and free PSA (fPSA) levels. We prospectively studied the impact of hemodialysis with low-flux membranes on serum tPSA, fPSA and free/total PSA (f/tPSA) ratios.
G. Özer   +4 more
doaj   +2 more sources

Comparison of hypofractionation and standard fractionation for post-prostatectomy salvage radiotherapy in patients with persistent PSA: single institution experience

open access: yesRadiation Oncology, 2021
Background Hypofractionated post-prostatectomy radiotherapy is emerging practice, however with no randomized evidence so far to support it’s use. Additionally, patients with persistent PSA after prostatectomy may have aggressive disease and respond less ...
Jure Murgic   +15 more
doaj   +1 more source

Home - About - Disclaimer - Privacy